1. Home
  2. STXS vs BWAY Comparison

STXS vs BWAY Comparison

Compare STXS & BWAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STXS
  • BWAY
  • Stock Information
  • Founded
  • STXS 1990
  • BWAY 2003
  • Country
  • STXS United States
  • BWAY Israel
  • Employees
  • STXS N/A
  • BWAY N/A
  • Industry
  • STXS Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • BWAY Medical/Dental Instruments
  • Sector
  • STXS Health Care
  • BWAY Health Care
  • Exchange
  • STXS Nasdaq
  • BWAY Nasdaq
  • Market Cap
  • STXS 151.3M
  • BWAY 201.1M
  • IPO Year
  • STXS 2004
  • BWAY 2019
  • Fundamental
  • Price
  • STXS $2.12
  • BWAY $12.98
  • Analyst Decision
  • STXS
  • BWAY Strong Buy
  • Analyst Count
  • STXS 0
  • BWAY 2
  • Target Price
  • STXS N/A
  • BWAY $14.25
  • AVG Volume (30 Days)
  • STXS 282.1K
  • BWAY 53.0K
  • Earning Date
  • STXS 08-11-2025
  • BWAY 08-05-2025
  • Dividend Yield
  • STXS N/A
  • BWAY N/A
  • EPS Growth
  • STXS N/A
  • BWAY N/A
  • EPS
  • STXS N/A
  • BWAY 0.08
  • Revenue
  • STXS $27,510,000.00
  • BWAY $43,457,000.00
  • Revenue This Year
  • STXS $25.90
  • BWAY $351.53
  • Revenue Next Year
  • STXS $60.57
  • BWAY $21.84
  • P/E Ratio
  • STXS N/A
  • BWAY $62.68
  • Revenue Growth
  • STXS 1.50
  • BWAY 26.86
  • 52 Week Low
  • STXS $1.54
  • BWAY $5.67
  • 52 Week High
  • STXS $2.72
  • BWAY $13.48
  • Technical
  • Relative Strength Index (RSI)
  • STXS 47.30
  • BWAY 72.08
  • Support Level
  • STXS $2.00
  • BWAY $10.84
  • Resistance Level
  • STXS $2.36
  • BWAY $13.35
  • Average True Range (ATR)
  • STXS 0.13
  • BWAY 0.51
  • MACD
  • STXS -0.01
  • BWAY 0.16
  • Stochastic Oscillator
  • STXS 31.58
  • BWAY 86.11

About STXS Stereotaxis Inc.

Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems; Disposables, Royalty; and Sublease, of which a majority of revenue is generated from the Disposables, service, and accessories stream.

About BWAY BrainsWay Ltd.

BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder, and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.

Share on Social Networks: